This presentation discusses the owner's perspective for potential of NZE in US hospitals at national scale. It discusses ideas from the US market contrasted to international viewpoints. How does the US perspective vary from the international perspectus? What do we need to be looking at to move the national portfolio to NZE? What are the biggest uses and how do we address them cost effectively? What is the cost and economic viability of NZE deployments and conversions? What synergies do NZE have with resilience that can make the economics more viable or feasible?